These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18279516)

  • 41. Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitors.
    McCormick DL; Phillips JM; Horn TL; Johnson WD; Steele VE; Lubet RA
    Cancer Prev Res (Phila); 2010 Jan; 3(1):73-81. PubMed ID: 20051374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Celecoxib enhanced the sensitivity of cancer cells to anticancer drugs by inhibition of the expression of P-glycoprotein through a COX-2-independent manner.
    Xia W; Zhao T; Lv J; Xu S; Shi J; Wang S; Han X; Sun Y
    J Cell Biochem; 2009 Sep; 108(1):181-94. PubMed ID: 19562670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
    Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV
    Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
    Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
    Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.
    Basu GD; Pathangey LB; Tinder TL; Lagioia M; Gendler SJ; Mukherjee P
    Mol Cancer Res; 2004 Nov; 2(11):632-42. PubMed ID: 15561779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model.
    Goss PE; Strasser-Weippl K; Qi S; Hu H
    BMC Cancer; 2007 Jan; 7():26. PubMed ID: 17266767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.
    Medina D; Kittrell F; Hill J; Zhang Y; Hilsenbeck SG; Bissonette R; Brown PH
    Cancer Prev Res (Phila); 2009 Feb; 2(2):168-74. PubMed ID: 19174577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice.
    Lanza-Jacoby S; Miller S; Flynn J; Gallatig K; Daskalakis C; Masferrer JL; Zweifel BS; Sembhi H; Russo IH
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1486-91. PubMed ID: 14693742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of estrogenic perturbations on delta-aminolevulinic acid-induced porphobilinogen deaminase and protoporphyrin IX levels in rat Harderian glands, liver, and R3230AC tumors.
    Gibson SL; Anderson LT; Havens JJ; Hilf R
    Biochem Pharmacol; 1999 Dec; 58(11):1821-9. PubMed ID: 10571258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells.
    Jeon YW; Suh YJ
    Oncol Rep; 2013 Feb; 29(2):819-25. PubMed ID: 23229294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chemopreventive effect of celecoxib against DMBA-induced breast cancer and its mechanism].
    Kang HF; Wang XJ; Liu XX; Dai ZJ; Xue FJ; Xue XH
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1599-602. PubMed ID: 17121709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats.
    Nakatsugi S; Ohta T; Kawamori T; Mutoh M; Tanigawa T; Watanabe K; Sugie S; Sugimura T; Wakabayashi K
    Jpn J Cancer Res; 2000 Sep; 91(9):886-92. PubMed ID: 11011115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model.
    Peterson NC; Servinsky MD; Christian A; Peng Z; Qiu W; Mann J; Dicello J; Huso DL
    Carcinogenesis; 2005 Sep; 26(9):1542-52. PubMed ID: 15860508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclooxygenase-2 inhibition for the prophylaxis and treatment of preinvasive breast cancer in a her-2/neu mouse model.
    Tran-Thanh D; Buttars S; Wen Y; Wilson C; Done SJ
    Cancer Prev Res (Phila); 2010 Feb; 3(2):202-11. PubMed ID: 20103725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of breast cancer: current state of the science and future opportunities.
    Uray IP; Brown PH
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1583-600. PubMed ID: 17107283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer.
    Barnes NL; Warnberg F; Farnie G; White D; Jiang W; Anderson E; Bundred NJ
    Br J Cancer; 2007 Feb; 96(4):575-82. PubMed ID: 17285134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model.
    Orengo IF; Gerguis J; Phillips R; Guevara A; Lewis AT; Black HS
    Arch Dermatol; 2002 Jun; 138(6):751-5. PubMed ID: 12056955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.
    Bocca C; Bozzo F; Bassignana A; Miglietta A
    Mol Cell Biochem; 2011 Apr; 350(1-2):59-70. PubMed ID: 21140284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
    Reddy BS; Patlolla JM; Simi B; Wang SH; Rao CV
    Cancer Res; 2005 Sep; 65(17):8022-7. PubMed ID: 16140976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.